Currently Viewing:
Association of Community Cancer Centers Annual Meeting
The Price of Innovation When Improving Cancer Care Delivery
March 15, 2018
Dr James Hamrick Outlines Challenges of Managing Clinical Trials and Benefits of Community Practices
March 15, 2018
Changing Trends in Oncology Practice: Value-Based Care and an Empowered Patient
March 15, 2018
Why Tom Gallo Wants to Address Burnout During His Year as ACCC President
March 15, 2018
Roger Holzberg Discusses Integrating Technology Into Healthcare
March 16, 2018
Investing in the Vital Role of a Cancer Care Coordinator
March 16, 2018
Barbara Tofani: The United States Underestimated the Need for Care Coordination
March 16, 2018
Technology Integration in Community Oncology Practice: Building the Future
March 16, 2018
Experts Emphasize the Value of Cancer Care Integration at ACCC Meeting
March 21, 2018
Tom Gallo: Burnout Needs to Be Addressed for All Members of the Care Team
April 03, 2018
Tom Gallo Discusses How Burnout Is Increasing and the Role of Technology
April 06, 2018
Dr Kathleen Blake Discusses the Impact Healthcare Industry Changes Have on Burnout
April 23, 2018
Dr Mark Soberman on the Next Generation Multidisciplinary Cancer Care Team
April 27, 2018
Dr Mark Soberman on the Importance of Communication Among Integrated Care Teams
May 01, 2018
Dr Charles Saunders Outlines the Increasing Importance of Technology in Practices
May 03, 2018
Barbara Tofani: The Old Ways of Coordinating Care Are Gone
May 07, 2018
Currently Reading
Dr James Hamrick: Community Practices Help Increase Diversity in Clinical Trials
May 08, 2018
Dr Yousuf Zafar Discusses the Burden of Financial Toxicity and Trends Over Time
May 14, 2018
Thomas Asfeldt Highlights 3 Key Challenges to Creating Integrated Cancer Care Teams
May 15, 2018
Pamela Tobias Discusses Pulling Data from EHRs to Improve Processes
May 15, 2018
Dr Mark Soberman Discusses Integrated Care Teams in Oncology
May 16, 2018
Dr Charles Saunders Highlights Data Collection Challenges
May 18, 2018
Dr Kathleen Blake Outlines How Burnout Affects Specialties Differently
May 21, 2018
Barbara Tofani Outlines Best Practices and Mistakes of Care Coordination
May 22, 2018

Dr James Hamrick: Community Practices Help Increase Diversity in Clinical Trials

Community practices are crucial for helping to increase diversity in clinical trials, said James Hamrick, MD, MPH, Kaiser Permanente and Flatiron Health.


Community practices are crucial for helping to increase diversity in clinical trials, said James Hamrick, MD, MPH, Kaiser Permanente and Flatiron Health.

Transcript

How can we diversify the patient population in clinical trials?

Diversity within clinical trials has been an issue for a long time and it continues to be. And, I think one thing that you can do with a huge community network, so one thing that community oncology can do is they can provider that denominator, so to speak, of patients that really do reflect the US population right now.

So, if you have a network that stretches across the country that’s rural and urban, that goes from small 1 doctor practices to very large, sophisticated practices with dozens of oncologists, then you really are getting a good snapshot of what the US population looks like. And that’s crucial, because we know that there are groups of patients that are traditionally underrepresented. Whether it be on racial lines or gender lines or age lines or socioeconomic lines, we know that the traditional clinical trials model that we’ve been operating under does not truly represent the real world. And oncologists know this well. We’ve always know it. And, so, you’re always trying to extrapolate. So, I think, having a network that touches all of the different places that cancer patients in our country get care is one huge step in terms of increasing diversity.

In addition, there is a shift in the mindset. So, there have been very good reasons for some populations in the United States to not trust clinical research. You think of Tuskegee [syphilis experiment] and it’s very reasonable to be skeptical of the motives of clinical research. I think we’re moving to an era where more and more people understand that we have a lot more safeguards for patients and research subjects now—that’s hugely important.

And, actually now people understand that, “Hey, the best cancer care is care that has access for cutting-edge trials.” So, I think that’s a transformative moment, and that’s a message that we need to continue to send as the oncology community is that: “You should be asking your doctor and your practice about access to trials.” Because that really is a hallmark of excellence in care.

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up